Dr. Katy Tsai, MD
Claim this profileUniversity of California- San Francisco
Studies Melanoma
Studies Solid Tumors
8 reported clinical trials
12 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
KIT positive
2Solid Tumors
Stage IV
BRAF positive
Stage III
Affiliated Hospitals
Clinical Trials Katy Tsai, MD is currently running
ABM-168
for Advanced Solid Tumors
This is a Phase 1, First-in-Human (FIH), open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ABM-168 in adult patients with RAS or RAF or NF-1 mutated advanced solid tumors as ABM-168 may have a significant effect in inhibiting cell growth.
Recruiting1 award Phase 1
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
More about Katy Tsai, MD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Katy Tsai, MD has experience with
- RP1
- Nivolumab
- Intra-tumoral Injection
- Ipilimumab
- Binimetinib
- Imatinib
Breakdown of trials Katy Tsai, MD has run
Melanoma
Solid Tumors
Tumors
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katy Tsai, MD specialize in?
Katy Tsai, MD focuses on Melanoma and Solid Tumors. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Katy Tsai, MD currently recruiting for clinical trials?
Yes, Katy Tsai, MD is currently recruiting for 6 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Katy Tsai, MD has studied deeply?
Yes, Katy Tsai, MD has studied treatments such as RP1, Nivolumab, Intra-tumoral Injection.
What is the best way to schedule an appointment with Katy Tsai, MD?
Apply for one of the trials that Katy Tsai, MD is conducting.
What is the office address of Katy Tsai, MD?
The office of Katy Tsai, MD is located at: University of California- San Francisco, San Francisco, California 94115 United States. This is the address for their practice at the University of California- San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.